Abiopharma

🔍 Bruehlman Ronald E (Director)

Company: GoodRx Holdings, Inc. (GDRX)

Report Date: 2026-01-01

Detailed Transactions and Holdings:

• Acquired 18,251 shares of Class A Common Stock (Direct)
  Date: 2026-01-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 129,276.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2026 and ending on December 31, 2026, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2031; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).